CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
about
Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis.HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.Targeting the ATR-CHK1 Axis in Cancer TherapyATR/CHK1 inhibitors and cancer therapy.Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 StatusThe Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
P2860
Q36229006-401E372C-6BC1-424A-A421-19BEC33D1C16Q37615630-B1360BC3-52C6-44BF-AE2D-69BB4D3028D7Q38719309-E47D6A1B-C444-4E4D-9FA6-A1CA60229353Q38817102-C9A69064-705D-4766-AA0E-8907C707897DQ47622968-CD682B3C-68DF-4F50-AD30-D1C6117638D3Q57176137-8F291115-8588-4804-921F-9ED07F981772Q58734520-BEAAD95A-6B9C-4CF1-8723-B27332D1A0E1
P2860
CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
CHK1 Inhibition Radiosensitize ...... taxel-Based Chemoradiotherapy.
@en
type
label
CHK1 Inhibition Radiosensitize ...... taxel-Based Chemoradiotherapy.
@en
prefLabel
CHK1 Inhibition Radiosensitize ...... taxel-Based Chemoradiotherapy.
@en
P2093
P1476
CHK1 Inhibition Radiosensitize ...... itaxel-Based Chemoradiotherapy
@en
P2093
Christopher M Nutting
Holly E Barker
Katie L Newbold
Kevin J Harrington
Radhika Patel
Shane Zaidi
Shreerang Bhide
Ulrike Schick
P304
P356
10.1158/1535-7163.MCT-15-0998
P577
2016-07-15T00:00:00Z